Kidney Transplant Unit, Nephrology Department, Hospital Universitari de Bellvitge, L' Hospitalet de Llobregat, Barcelona, Spain.
Kidney Transplant Unit, Nephrology Department, Hospital Universitari Vall Hebrón, Barcelona, Spain.
Transpl Int. 2021 Dec;34(12):2494-2506. doi: 10.1111/tri.14131. Epub 2021 Oct 28.
Outcomes of kidney transplantation (KT) after controlled circulatory death (cDCD) with highly expanded criteria donors (ECD) and recipients have not been thoroughly evaluated. We analyzed in a multicenter cohort of 1161 consecutive KT, granular baseline donor and recipient factors predicting transplant outcomes, selected by bootstrapping and Cox proportional hazards, and were validated in a contemporaneous European KT cohort (n = 1585). 74.3% were DBD and 25.7% cDCD-KT. ECD-KT showed the poorest graft survival rates, irrespective of cDCD or DBD (log-rank < 0.001). Besides standard ECD classification, dialysis vintage, older age, and previous cardiovascular recipient events together with low class-II-HLA match, long cold ischemia time and combining a diabetic donor with a cDCD predicted graft loss (C-Index 0.715, 95% CI 0.675-0.755). External validation showed good prediction accuracy (C-Index 0.697, 95%CI 0.643-0.741). Recipient older age, male gender, dialysis vintage, previous cardiovascular events, and receiving a cDCD independently predicted patient death. Benefit/risk assessment of undergoing KT was compared with concurrent waitlisted candidates, and despite the fact that undergoing KT outperformed remaining waitlisted, remarkably high mortality rates were predicted if KT was undertaken under the worst risk-prediction model. Strategies to increase the donor pool, including cDCD transplants with highly expanded donor and recipient candidates, should be performed with caution.
在广泛扩展的供体标准下,控制性循环死亡(cDCD)后肾移植(KT)的结果(和接受者)尚未得到彻底评估。我们通过Bootstrap 和 Cox 比例风险分析,对 1161 例连续 KT 的多中心队列中的颗粒状基线供体和受者因素进行了分析,这些因素预测了移植结果,并在同期欧洲 KT 队列(n=1585)中进行了验证。74.3%为 DBD,25.7%为 cDCD-KT。无论 cDCD 还是 DBD,ECD-KT 的移植物存活率均最差(对数秩检验<0.001)。除了标准的 ECD 分类外,透析龄、年龄较大、以及先前的心血管受者事件,加上 II 类 HLA 匹配度低、冷缺血时间长和将糖尿病供体与 cDCD 相结合,都预测了移植物丢失(C 指数 0.715,95%CI 0.675-0.755)。外部验证显示了良好的预测准确性(C 指数 0.697,95%CI 0.643-0.741)。受者年龄较大、男性、透析龄、先前的心血管事件以及接受 cDCD 独立预测了患者死亡。将接受 KT 与同期候补候选人进行了获益/风险评估,尽管接受 KT 比继续候补等待表现要好,但如果根据风险预测模型最差的情况下进行 KT,预计死亡率会非常高。应谨慎地采取增加供体库的策略,包括采用广泛扩展的供体和受者候选者进行 cDCD 移植。